Positron Corporation (POSC)
USD 1.44
(-24.21%)
USD 1.44
(-24.21%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.02 Million USD | 7.3% |
| 2022 | 1.88 Million USD | 451.45% |
| 2021 | 342.4 Thousand USD | -32.91% |
| 2020 | 510.39 Thousand USD | -55.71% |
| 2019 | 1.15 Million USD | -4.71% |
| 2018 | 1.2 Million USD | 0.0% |
| 2014 | 2.7 Million USD | -82.11% |
| 2013 | 15.12 Million USD | 70.4% |
| 2012 | 8.87 Million USD | 71.46% |
| 2011 | 5.17 Million USD | -1.58% |
| 2010 | 5.25 Million USD | -33.82% |
| 2009 | 7.94 Million USD | 3.83% |
| 2008 | 7.65 Million USD | 6.01% |
| 2007 | 7.22 Million USD | 9.88% |
| 2006 | 6.57 Million USD | 72.33% |
| 2005 | 3.81 Million USD | 15.13% |
| 2004 | 3.31 Million USD | 52.49% |
| 2003 | 2.17 Million USD | -66.2% |
| 2002 | 6.42 Million USD | 31.49% |
| 2001 | 4.88 Million USD | 57.49% |
| 2000 | 3.1 Million USD | -22.02% |
| 1999 | 3.97 Million USD | -37.09% |
| 1998 | 6.32 Million USD | -6.71% |
| 1997 | 6.78 Million USD | 9.8% |
| 1996 | 6.17 Million USD | 34.24% |
| 1995 | 4.6 Million USD | 100.0% |
| 1994 | 2.3 Million USD | -36.11% |
| 1993 | 3.6 Million USD | -63.27% |
| 1992 | 9.8 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 2.06 Million USD | 2.15% |
| 2023 FY | 2.02 Million USD | 7.3% |
| 2023 Q4 | 2.02 Million USD | -7.04% |
| 2023 Q3 | 2.17 Million USD | 2.83% |
| 2023 Q2 | 2.11 Million USD | 13.88% |
| 2023 Q1 | 1.86 Million USD | -1.43% |
| 2022 Q2 | 419.04 Thousand USD | 22.86% |
| 2022 Q3 | 1.51 Million USD | 262.29% |
| 2022 FY | 1.88 Million USD | 451.45% |
| 2022 Q1 | 341.07 Thousand USD | -0.39% |
| 2022 Q4 | 1.88 Million USD | 24.37% |
| 2021 FY | 342.4 Thousand USD | -32.91% |
| 2021 Q1 | 589.22 Thousand USD | 0.0% |
| 2021 Q4 | 342.4 Thousand USD | -20.43% |
| 2021 Q3 | 430.29 Thousand USD | -11.95% |
| 2021 Q2 | 488.71 Thousand USD | -17.06% |
| 2020 FY | 510.39 Thousand USD | -55.71% |
| 2019 FY | 1.15 Million USD | -4.71% |
| 2018 FY | 1.2 Million USD | 0.0% |
| 2015 Q1 | 2.63 Million USD | -2.51% |
| 2015 Q2 | 2.97 Million USD | 12.59% |
| 2015 Q3 | 3.1 Million USD | 4.48% |
| 2014 FY | 2.7 Million USD | -82.11% |
| 2014 Q4 | 2.7 Million USD | -10.99% |
| 2014 Q3 | 3.04 Million USD | -54.54% |
| 2014 Q1 | 15.3 Million USD | 1.22% |
| 2014 Q2 | 6.68 Million USD | -56.32% |
| 2013 Q1 | 9.84 Million USD | 10.94% |
| 2013 FY | 15.12 Million USD | 70.4% |
| 2013 Q4 | 15.12 Million USD | 31.49% |
| 2013 Q3 | 11.5 Million USD | 10.62% |
| 2013 Q2 | 10.39 Million USD | 5.6% |
| 2012 Q3 | 8.1 Million USD | 36.58% |
| 2012 Q1 | 7.2 Million USD | 39.2% |
| 2012 FY | 8.87 Million USD | 71.46% |
| 2012 Q4 | 8.87 Million USD | 9.45% |
| 2012 Q2 | 5.93 Million USD | -17.6% |
| 2011 Q1 | 4.32 Million USD | -17.7% |
| 2011 FY | 5.17 Million USD | -1.58% |
| 2011 Q4 | 5.17 Million USD | 1.03% |
| 2011 Q3 | 5.12 Million USD | 18.29% |
| 2011 Q2 | 4.33 Million USD | 0.07% |
| 2010 Q4 | 5.25 Million USD | 4.02% |
| 2010 Q3 | 5.05 Million USD | -53.25% |
| 2010 FY | 5.25 Million USD | -33.82% |
| 2010 Q1 | 9.14 Million USD | 15.1% |
| 2010 Q2 | 10.81 Million USD | 18.22% |
| 2009 Q3 | 7.65 Million USD | -3.58% |
| 2009 Q2 | 7.93 Million USD | 3.83% |
| 2009 Q1 | 7.64 Million USD | -0.16% |
| 2009 FY | 7.94 Million USD | 3.83% |
| 2009 Q4 | 7.94 Million USD | 3.87% |
| 2008 FY | 7.65 Million USD | 6.01% |
| 2008 Q3 | 10.66 Million USD | -11.93% |
| 2008 Q2 | 12.1 Million USD | 74.36% |
| 2008 Q1 | 6.94 Million USD | -3.85% |
| 2008 Q4 | 7.65 Million USD | -28.2% |
| 2007 Q2 | 8.4 Million USD | 7.08% |
| 2007 Q3 | 6.39 Million USD | -23.96% |
| 2007 Q4 | 7.22 Million USD | 12.95% |
| 2007 Q1 | 7.85 Million USD | 19.46% |
| 2007 FY | 7.22 Million USD | 9.88% |
| 2006 Q3 | 3.82 Million USD | -41.74% |
| 2006 FY | 6.57 Million USD | 72.33% |
| 2006 Q1 | 4.65 Million USD | 21.98% |
| 2006 Q2 | 6.56 Million USD | 41.09% |
| 2006 Q4 | 6.57 Million USD | 71.88% |
| 2005 Q4 | 3.81 Million USD | 0.82% |
| 2005 FY | 3.81 Million USD | 15.13% |
| 2005 Q3 | 3.78 Million USD | 22.59% |
| 2005 Q2 | 3.08 Million USD | -10.71% |
| 2005 Q1 | 3.45 Million USD | 4.32% |
| 2004 Q2 | 3.85 Million USD | 48.8% |
| 2004 Q3 | 3.09 Million USD | -19.78% |
| 2004 Q4 | 3.31 Million USD | 7.05% |
| 2004 Q1 | 2.59 Million USD | 19.34% |
| 2004 FY | 3.31 Million USD | 52.49% |
| 2003 Q4 | 2.17 Million USD | 13.96% |
| 2003 Q1 | 4.57 Million USD | -28.77% |
| 2003 FY | 2.17 Million USD | -66.2% |
| 2003 Q3 | 1.9 Million USD | 11.07% |
| 2003 Q2 | 1.71 Million USD | -62.51% |
| 2002 Q3 | 4.59 Million USD | 11.18% |
| 2002 Q4 | 6.42 Million USD | 39.88% |
| 2002 Q2 | 4.13 Million USD | -17.38% |
| 2002 Q1 | 5 Million USD | 2.33% |
| 2002 FY | 6.42 Million USD | 31.49% |
| 2001 Q4 | 4.88 Million USD | 10.64% |
| 2001 Q3 | 4.41 Million USD | 1.96% |
| 2001 Q2 | 4.33 Million USD | 20.37% |
| 2001 Q1 | 3.59 Million USD | 15.98% |
| 2001 FY | 4.88 Million USD | 57.49% |
| 2000 Q4 | 3.1 Million USD | 39.59% |
| 2000 Q1 | 3.99 Million USD | 0.0% |
| 2000 Q2 | 4.24 Million USD | 6.05% |
| 2000 Q3 | 2.22 Million USD | -47.57% |
| 2000 FY | 3.1 Million USD | -22.02% |
| 1999 FY | 3.97 Million USD | -37.09% |
| 1998 FY | 6.32 Million USD | -6.71% |
| 1997 FY | 6.78 Million USD | 9.8% |
| 1997 Q1 | 7 Million USD | 13.36% |
| 1996 FY | 6.17 Million USD | 34.24% |
| 1996 Q4 | 6.17 Million USD | 43.6% |
| 1996 Q3 | 4.3 Million USD | 0.0% |
| 1996 Q1 | 4 Million USD | -13.04% |
| 1996 Q2 | 4.3 Million USD | 7.5% |
| 1995 Q1 | 1.4 Million USD | -39.13% |
| 1995 FY | 4.6 Million USD | 100.0% |
| 1995 Q3 | 3.3 Million USD | 106.25% |
| 1995 Q4 | 4.6 Million USD | 39.39% |
| 1995 Q2 | 1.6 Million USD | 14.29% |
| 1994 Q2 | 1.7 Million USD | -46.88% |
| 1994 Q3 | 1.7 Million USD | 0.0% |
| 1994 FY | 2.3 Million USD | -36.11% |
| 1994 Q4 | 2.3 Million USD | 35.29% |
| 1994 Q1 | 3.2 Million USD | -11.11% |
| 1993 Q4 | 3.6 Million USD | 0.0% |
| 1993 FY | 3.6 Million USD | -63.27% |
| 1992 Q4 | 9.8 Million USD | 0.0% |
| 1992 FY | 9.8 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Avitar, Inc. | 11.59 Million USD | 82.525% |
| BioElectronics Corporation | 16.62 Million USD | 87.812% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | 634 Thousand USD | -219.558% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | -198.989% |
| Polarean Imaging plc | 2.58 Million USD | 21.489% |
| AVITA Medical, Inc. | 19.86 Million USD | 89.801% |
| Manhattan Scientifics, Inc. | 2.11 Million USD | 4.344% |
| Össur hf. | 688.8 Million USD | 99.706% |
| Zecotek Photonics Inc. | 5.86 Million USD | 65.477% |
| QHSLab, Inc. | 2.05 Million USD | 1.509% |
| Wellstar International, Inc. | 55.99 Million USD | 96.382% |
| Össur hf. | 688.8 Million USD | 99.706% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | 87.401% |
| Escalon Medical Corp. | 2.94 Million USD | 31.284% |
| Aurora Spine Corporation | 6.65 Million USD | 69.55% |
| BrainsWay Ltd. | 15.31 Million USD | 86.77% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 6.01 Million USD | 66.304% |
| Hamilton Thorne Ltd. | 45.84 Million USD | 95.581% |
| Vivos Inc. | 245 Thousand USD | -726.924% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 99.919% |
| Kelyniam Global, Inc. | 1.01 Million USD | -100.013% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | -635.085% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | 17.3% |
| Nanomix Corporation | 14.81 Million USD | 86.324% |
| Theraclion SA | 13.01 Million EUR | 84.435% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 5.12 Million USD | 60.462% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | 44.051% |
| Lombard Medical, Inc. | 53.79 Million USD | 96.234% |
| ALR Technologies Inc. | 24.5 Million USD | 91.732% |
| Stratec SE | 271.97 Million USD | 99.255% |
| Vycor Medical, Inc. | 4.31 Million USD | 53.078% |
| Heart Tronics, Inc. | 1.09 Million USD | -85.058% |
| Nu-Med Plus, Inc. | 2.35 Million USD | 14.108% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | 63.006% |
| SANUWAVE Health, Inc. | 65.59 Million USD | 96.911% |
| VMS Rehab Systems, Inc. | 201.36 USD | -1006057.132% |
| Guided Therapeutics, Inc. | 5.47 Million USD | 62.995% |
| Ingen Technologies, Inc. | 5.7 Million USD | 64.516% |
| Odyssey Group International, Inc. | 6.61 Million USD | 69.357% |
| United American Healthcare Corporation | 119 Thousand USD | -1602.519% |
| ECGI Holdings, Inc. | 11.94 Million USD | 83.032% |
| Capital Group Holdings, Inc. | 1.32 Million USD | -53.023% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | -40.078% |
| Urologix, Inc. | 12.64 Million USD | 83.977% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | 62.454% |
| Nexeon MedSystems Inc. | 8.48 Million USD | 76.115% |
| SS Innovations International, Inc. | 11.18 Million USD | 81.88% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | -285.62% |
| Smith & Nephew plc | 4.76 Billion USD | 99.957% |
| NIOX Group Plc | 9.8 Million USD | 79.331% |
| Fuse Medical, Inc. | 15.11 Million USD | 86.592% |
| Broncus Holding Corporation | 10.43 Million USD | 80.579% |
| Brain Scientific Inc. | 7.42 Million USD | 72.719% |
| Pressure BioSciences, Inc. | 33.8 Million USD | 94.007% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | -155.137% |